Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Prepaid Assets: 2019-2024

Historic Prepaid Assets for Legend Biotech (LEGN) over the last 6 years, with Dec 2024 value amounting to $131.0 million.

  • Legend Biotech's Prepaid Assets rose 598.52% to $219.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $219.0 million, marking a year-over-year increase of 598.52%. This contributed to the annual value of $131.0 million for FY2024, which is 89.13% up from last year.
  • As of FY2024, Legend Biotech's Prepaid Assets stood at $131.0 million, which was up 89.13% from $69.3 million recorded in FY2023.
  • Legend Biotech's Prepaid Assets' 5-year high stood at $131.0 million during FY2024, with a 5-year trough of $10.5 million in FY2020.
  • Its 3-year average for Prepaid Assets is $87.3 million, with a median of $69.3 million in 2023.
  • Per our database at Business Quant, Legend Biotech's Prepaid Assets plummeted by 37.70% in 2020 and then soared by 345.82% in 2022.
  • Yearly analysis of 5 years shows Legend Biotech's Prepaid Assets stood at $10.5 million in 2020, then surged by 32.53% to $13.9 million in 2021, then surged by 345.82% to $61.8 million in 2022, then grew by 12.14% to $69.3 million in 2023, then soared by 89.13% to $131.0 million in 2024.